Read the qualifier, not only the disease name
Rheumatic disorders on the solution label are adjunctive therapy for short-term administration, to tide the patient over an acute episode or exacerbation. The same paragraph says selected cases of juvenile rheumatoid arthritis may require low-dose maintenance therapy. A flare bridge and a maintenance case are both on the label. They are not the same plan.
Allergic states are limited to severe or incapacitating conditions intractable to adequate trials of conventional treatment. Bronchial asthma sits in that allergic list, beside allergic rhinitis, contact dermatitis, atopic dermatitis, serum sickness, and drug hypersensitivity. The label is not an instruction to swap an inhaled medicine for prednisolone on an ordinary day.
Collagen-disease lines cover an exacerbation, or maintenance in selected cases, of systemic lupus erythematosus and acute rheumatic carditis. Gastrointestinal lines are there to tide the patient over a critical period of ulcerative colitis or regional enteritis. Nephrotic syndrome is listed to induce a diuresis or a remission of proteinuria, without uremia, of the idiopathic type or due to lupus. Cancer lines are palliative management of acute leukemia of childhood and of leukemias and lymphomas in adults.
An infections list is easy to borrow
Major clinic and consumer references describe prednisolone for inflammation, allergy, arthritis, asthma, or inflammatory bowel disease when the label supports the line. Some adjacent pages still talk about prednisone. Match the molecule on the page you are reading to the molecule on the prescription.
The US solution label does not treat "infections" as a general use. Its narrow infection lines are different. Fulminating or disseminated pulmonary tuberculosis is listed when the steroid is used concurrently with appropriate chemotherapy. Tuberculous meningitis with subarachnoid block is listed the same way, with appropriate antituberculous chemotherapy. Trichinosis is listed when there is neurologic or myocardial involvement. Those are concurrent-treatment settings. They are not a reason to start prednisolone for an ordinary cough.
The same label says corticosteroids, including prednisolone oral solution, suppress the immune system and increase the risk of infection. Systemic fungal infection is a contraindication to starting the solution. A page that puts "infections" in the same breath as allergies is easy to misread. The US line is the qualifier, plus the warning.
Adrenal replacement is not the inflammatory job
Primary or secondary adrenocortical insufficiency is on the solution label, and the label says hydrocortisone or cortisone is the first choice. Synthetic analogs may be used in conjunction with mineralocorticoids where applicable. In infancy, mineralocorticoid supplementation is of particular importance. Prednisolone for a swollen joint and prednisolone as an adrenal stand-in are different jobs on the same sheet.
Skin, eye, and blood lines are real and still qualified. The dermatologic list includes pemphigus, severe psoriasis, and severe erythema multiforme (Stevens-Johnson syndrome), among other severe skin diseases. Eye lines are severe acute and chronic allergic and inflammatory processes involving the eye. Adult hematologic lines include idiopathic thrombocytopenic purpura in adults and acquired (autoimmune) hemolytic anemia. None of those names, by itself, sets the dose or the stop date.
One starting range, not one dose per disease
The initial dosage of this oral solution may vary from 5 mg to 60 mg per day depending on the disease being treated. The label says severity, prognosis, expected duration, and the reaction to the medicine are primary factors in determining dosage. Orapred ODT, the dissolving tablet, is a corticosteroid indicated as an anti-inflammatory or immunosuppressive agent across a similar spread of body systems, and its own initial range is 10 to 60 mg of prednisolone base per day. Matching a disease name does not match the product.
The opened solution text lists indications. It does not attach a cure rate or a ranking of trials to each line. A stacked list of uses is a map of common questions. It is not a substitute for the qualifier on the labeled line that matches the person.
How a course comes down is the separate note on prednisolone tapering. How the molecule was developed is prednisolone history. The access page is prednisolone. The solution text used here is the prednisolone oral solution DailyMed label, opened 24 October 2026.